{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_3820", "batch_size": 200, "batch_pos": 146, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment describes discussions factually, without high-potency language.", "method": "llm_batch", "batch_id": "batch_2_18732", "batch_size": 200, "batch_pos": 109, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "No moderate verb paired with explicit scale/impact.", "method": "llm_batch", "batch_id": "batch_3_12084", "batch_size": 200, "batch_pos": 31, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_19736", "batch_size": 200, "batch_pos": 26, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment reports discussions but contains no explicit calming cues.", "method": "llm_batch", "batch_id": "batch_5_5232", "batch_size": 200, "batch_pos": 20, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_18968", "batch_size": 200, "batch_pos": 168, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_18812", "batch_size": 200, "batch_pos": 144, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "States 'we are in discussions... on advancing our pandemic flu candidate', which is a development/capability measure.", "method": "llm_batch", "batch_id": "batch_8_16356", "batch_size": 200, "batch_pos": 173, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
